Estamos no ar no ! Saiba mais
ícone de OGI

Organigram Holdings

0,9267 USD
-0,0049
0,53%
No fechamento Atualizado 16 de out. 16:00 EDT
Pré-mercado
Após o fechamento do mercado
0,9196
-0,0071
0,77%
1 dia
-0,53%
5 dias
-2,73%
1 mês
-12,58%
3 meses
6,37%
6 meses
-39,03%
No acumulado do ano
-46,43%
1 ano
-50,97%
5 anos
-89,52%
10 anos
-97,03%
 

Sobre: Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Funcionários: 1.137

Notícias

Positivo
Neutro
Negativo
Sentimento 3 meses
Positivo 16,7%
Neutro 83,3%
Negativo 0%
Neutro
Business Wire
ontem
Organigram Provides Update on Integration of Sanity Group and Unified Global Operating Model
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1 and a growing global cannabis platform, today provided an update on the previously announced accelerated integration of Sanity Group GmbH (“Sanity Group”) and unified global operating model, which completes the integration of Sanity Group and aligns the Company as one enterprise. The Company expects these actions, which include a series of oper.
Organigram Provides Update on Integration of Sanity Group and Unified Global Operating Model
Neutro
Seeking Alpha
há 16 dias
Organigram Global Inc. (OGI:CA) Discusses Strategic Priorities, Growth Initiatives, and Insights from Production Facilities Transcript
Organigram Global Inc. (OGI:CA) Discusses Strategic Priorities, Growth Initiatives, and Insights from Production Facilities Transcript
Organigram Global Inc. (OGI:CA) Discusses Strategic Priorities, Growth Initiatives, and Insights from Production Facilities Transcript
Positivo
MarketBeat
há 16 dias
Organigram Global Targets Profitable Growth With Canada Focus and German Expansion
Organigram Global NASDAQ: OGI outlined a strategy centered on protecting its Canadian market position while increasing profitability, expanding internationally through its Sanity Group acquisition, improving manufacturing efficiency and applying stricter capital-allocation discipline.
Organigram Global Targets Profitable Growth With Canada Focus and German Expansion
Neutro
Business Wire
há 16 dias
Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram") is pleased to announce that the 2026 OG Investor Session will premiere today, September 30, 2026, at 4:00 p.m. ET on the Company's X account at https://x.com/Organigram_Inc. The session will also be simulcast on Organigram's LinkedIn and YouTube channels. “We designed this year's OG Investor Session around the questions we hear most often from investors — where the next phase of growth come.
Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X
Neutro
Business Wire
mês passado
Organigram Global to Host 2026 OG Investor Session
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform, today announced details of its 2026 OG Investor Session. “Since our last investor session, we've welcomed a new leadership team, completed our first full quarter with Sanity Group, and sharpened our strategy for the years ahead. We look forward to updating our stakeholders on how we're aligning Organigram.
Organigram Global to Host 2026 OG Investor Session
Neutro
Business Wire
mês passado
Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram” or the “Company”) today announced an important milestone in its global growth strategy through the accelerated integration of Sanity Group GmbH (“Sanity”) and the alignment of leadership, operations and market development activities across the combined organization. To support the combined organization, Organigram has appointed Finn Age Hänsel as President, Rest of World & Chief Strategy Officer, and Adr.
Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
Neutro
Seeking Alpha
há 2 meses
Organigram Global Inc. (OGI:CA) Q3 2026 Earnings Call Transcript
Organigram Global Inc. (OGI:CA) Q3 2026 Earnings Call Transcript
Organigram Global Inc. (OGI:CA) Q3 2026 Earnings Call Transcript
Neutro
Zacks Investment Research
há 2 meses
OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.03 per share a year ago.
OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates
Positivo
MarketBeat
há 2 meses
Organigram Global Q3 Earnings Call Highlights
Organigram Global NASDAQ: OGI reported record third-quarter fiscal 2026 revenue and adjusted EBITDA, aided by the consolidation of Germany-based Sanity Group and improving performance in several Canadian cannabis categories.
Organigram Global Q3 Earnings Call Highlights
Neutro
Business Wire
há 2 meses
Organigram Reports Record Third Quarter Fiscal 2026 Results
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share2 and a growing global cannabis platform following its acquisition of Sanity Group GmbH (“Sanity” or “Sanity Group”), today announced its results for the third quarter ended June 30, 2026 (“Q3 Fiscal 2026” or “Q3”). Q3 FISCAL 2026 HIGHLIGHTS Gross Revenue: $145.1 million (+32% year-over-year). Net Revenue: $105.8 million (+49% year-over-year). A.
Organigram Reports Record Third Quarter Fiscal 2026 Results
Gráficos de preços implementados com Lightweight Charts™